WASHINGTON, Sept. 10, 2013 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical
company focused on the development and commercialization of
products for the treatment of central nervous system disorders,
today announced that it will deliver a corporate presentation at
the Stifel Nicolaus 2013 Healthcare Conference in Boston on Thursday,
September 12, 2013 at 2:05 p.m.
Eastern Time.
The presentation at the Stifel Nicolaus 2013 Healthcare
Conference will be available live on Vanda's corporate website,
where it also will be archived for 30 days. To access the
presentation, go to Vanda's website at www.vandapharma.com and
click on the Presentations tab on the Investor Relations page.
Please connect to the website several minutes prior to the
start of the live presentation.
About Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company
focused on the development and commercialization of products for
the treatment of central nervous system disorders. For more on
Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.
Company Contact:
Jim
Kelly
Senior Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com
SOURCE Vanda Pharmaceuticals Inc.